Scope clot removal plus steroid for deep brain bleed
Part of Brain & nervous system, Heart & circulation clinical trials.
This study tests a combination approach—using a scope through a small skull opening to remove the clot from a deep brain bleed (basal ganglia), then giving a steroid called methylprednisolone to reduce inflammation. It may help people with a moderate-sized bleed who get treated within 24 hours.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have a spontaneous (not caused by injury) bleed in an area deep in the brain called the basal ganglia, confirmed by CT scan.
- The bleed happened within the last 24 hours and the amount of bleeding is between 30 and 80 ml.
- Your stroke symptoms are noticeable (NIHSS score of 6 or higher) and your level of consciousness is moderately affected (GCS score between 5 and 14).
- You have not had any recent brain hemorrhage surgery, do not have certain blood clotting problems, and are not on strong blood thinners.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a procedure that uses a small camera to remove the blood clot from the brain, combined with a steroid medication, to reduce damage from a brain bleed. It may be an option for people with a moderate-to-large brain bleed in the outer part of the brain who can be treated within 24 hours.
This trial tests whether a minimally invasive brain surgery using an endoscope can improve outcomes for people with a deep brain bleed. It also studies the safety of this approach compared with standard care.
This trial tests a minimally invasive surgery to remove blood clots deep in the brain after a spontaneous bleed. It may help patients with moderate to large bleeds who are at least 18 and up to 80 years old.
This trial tests a type of keyhole surgery called neuroendoscopic surgery to remove large blood clots in the brain. It may help people who have had a serious brain bleed and need urgent surgery.
This trial tests a minimally invasive surgery to remove blood clots deep in the brain caused by spontaneous bleeding. It aims to improve recovery for patients who meet specific criteria, such as clot size and time since symptoms started.
This trial tests a less invasive surgery to remove small blood clots (20–30 ml) in the basal ganglia, a deep part of the brain. It may help people who are awake but have a reduced level of consciousness after a recent brain bleed.
Hear when a new Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.